Cart
sales@molnova.com
VPS34 inhibitor 1 (Compound 19 PIK-III analogue)
CAS No. 1383716-46-8
VPS34 inhibitor 1 (Compound 19 PIK-III analogue)( PIK-III analogue )
Catalog No. M21136 CAS No. 1383716-46-8
VPS34 inhibitor 1 (Compound 19 PIK-III analogue) is a potent and selective inhibitor of VPS34( IC50 : 15 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 154 | In Stock |
|
| 5MG | 140 | In Stock |
|
| 10MG | 227 | In Stock |
|
| 25MG | 398 | In Stock |
|
| 50MG | 554 | In Stock |
|
| 100MG | 737 | In Stock |
|
| 200MG | 1014 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVPS34 inhibitor 1 (Compound 19 PIK-III analogue)
-
NoteResearch use only, not for human use.
-
Brief DescriptionVPS34 inhibitor 1 (Compound 19 PIK-III analogue) is a potent and selective inhibitor of VPS34( IC50 : 15 nM).
-
DescriptionVPS34 inhibitor 1 (Compound 19 PIK-III analogue) is a potent and selective inhibitor of VPS34( IC50 : 15 nM).
-
In Vitro——
-
In Vivo——
-
SynonymsPIK-III analogue
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorVps34
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1383716-46-8
-
Formula Weight391.47
-
Molecular FormulaC21H25N7O
-
Purity>98% (HPLC)
-
SolubilityDMSO:78 mg/mL (199.25 mM)
-
SMILESCC(C)(O)CNc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Honda A Harrington E Cornella-Taracido I et al. Potent Selective and Orally Bioavailable Inhibitors of VPS34 Provide Chemical Tools to Modulate Autophagy in Vivo[J]. ACS Medicinal Chemistry Letters 2015 7(1).
molnova catalog
related products
-
AS-605240
AS-605240 (AS605240) is a potent, selective, ATP-competitive, orally active PI3Kγ inhibitor.
-
Copanlisib dihydroch...
Copanlisib dihydrochloride is an ATP-competitive pan-class I PI3K inhibitor (IC50s: 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ).
-
GSK-2636771
GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. Phase 1/2a.
